Document 2662
 DOCN  M94A2662
 TI    HIV testing sexually abused children: reducing uncertain clinical
       decision-making.
 DT    9412
 AU    Durfee M; Gellert GA; Berkowitz C; LA Dept Health, CA 90012.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):253 (abstract no. PB0443). Unique
       Identifier : AIDSLINE ICA10/94369913
 AB    OBJECTIVE: To review the existing literature in search of guidelines for
       deciding when to test the sexually abused child for HIV. METHODS:
       Clinicians who care for sexually abused children are faced with
       considerable difficulties in determining whether or not to test specific
       children for HIV antibody. Data on this issue must be collected
       prospectively to demonstrate the frequency with which seroconversion
       follows abuse, stratified by variables specific to abuse such as type
       and duration of assault. No current report providing these data can be
       found in the literature. Thus definitive guidelines for HIV antibody
       testing of sexually abused children must be derived from an incomplete
       database, and physicians must make the critical test decision absent
       data on risk of HIV transmission. We reviewed a study of 28 children
       infected with HIV from abuse. RESULTS: Using situational and
       sociodemographic data on 28 children infected with HIV having no other
       risk factors, this discussion willarticulate strategies that may assist
       the clinician in deciding when and when not to test sexually abused
       children for HIV antibody, including perpetrator serostatus and
       behavioral profile, co-existence of other STDs, and other factors.
       CONCLUSION: Guidelines for test decision-making guidelines, short of
       universal screening of all sexually abused children, may be derived from
       existing data and can be more systematically applied by clinicians.
 DE    *AIDS Serodiagnosis  Child  Child Abuse, Sexual/*EPIDEMIOLOGY  Human
       HIV Seropositivity/DIAGNOSIS/EPIDEMIOLOGY/*TRANSMISSION  HIV
       Seroprevalence  Risk Factors  United States  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).